Skip to content

Clinical trials

Phase 1/2 Myocardial Infarction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 1/2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20082
20102
20111
20121
20131
20151
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University2
University of Rochester2
Abbott Medical Devices1
Angioblast Systems1
Capricor Inc.1
Center for Veterans Research and Education1
Joshua M Hare1
KAI Pharmaceuticals1
Serpin Pharma, LLC1
Southern Illinois University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction13
Heart Failure2
Mitral Valve Insufficiency2
Acute Coronary Syndrome1
Cardiovascular Diseases1
Coronary Artery Disease1
Infarction1
Inflammation1
Mitral Valve Prolapse1
Neoplasm Metastasis1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.